急诊PCI术后急性造影剂相关性肾损伤发生情况及其影响因素分析

杨坤, 陈剑飞, 刘林琼, 等. 急诊PCI术后急性造影剂相关性肾损伤发生情况及其影响因素分析[J]. 临床急诊杂志, 2021, 22(6): 390-394. doi: 10.13201/j.issn.1009-5918.2021.06.005
引用本文: 杨坤, 陈剑飞, 刘林琼, 等. 急诊PCI术后急性造影剂相关性肾损伤发生情况及其影响因素分析[J]. 临床急诊杂志, 2021, 22(6): 390-394. doi: 10.13201/j.issn.1009-5918.2021.06.005
YANG Kun, CHEN Jianfei, LIU Linqiong, et al. Analysis of the incidence and influencing factors of acute contrast induced renal injury after emergency PCI[J]. J Clin Emerg, 2021, 22(6): 390-394. doi: 10.13201/j.issn.1009-5918.2021.06.005
Citation: YANG Kun, CHEN Jianfei, LIU Linqiong, et al. Analysis of the incidence and influencing factors of acute contrast induced renal injury after emergency PCI[J]. J Clin Emerg, 2021, 22(6): 390-394. doi: 10.13201/j.issn.1009-5918.2021.06.005

急诊PCI术后急性造影剂相关性肾损伤发生情况及其影响因素分析

  • 基金项目:

    重庆市科卫联合医学科研项目(No:2020GDC016)

    重庆市巴南区科技计划项目(No:2019-19)

详细信息
    通讯作者: 陈剑飞,E-mail:caosha81215@163.com
  • 中图分类号: R541.4

Analysis of the incidence and influencing factors of acute contrast induced renal injury after emergency PCI

More Information
  • 目的:探讨急诊PCI术后造影剂相关性急性肾损伤(CI-AKI)发生情况及其影响因素。方法:选择2018年3月-2020年4月期间我院行冠状动脉造影及急诊PCI治疗的急性冠脉综合征患者294例进行研究。收集可能引起CI-AKI的影响因素,在单因素分析基础上行多因素Logistic回归分析以判断各因素对患者CI-AKI的综合影响。结果:本次调查的294例患者中共出现34例(11.56%)CI-AKI,单因素基础上多因素分析结果显示:有糖尿病史(OR=1.449,95%CI:1.043~2.014)、低密度脂蛋白高于正常值(OR=1.502,95%CI:1.045~2.159)、eGFR<60 mL/(min·1.73 m2)(OR=1.426,95%CI:1.008~2.018)、左心室射血分数<55%(OR=1.416,95%CI:1.017~1.972)、造影剂接触时间延长(OR=1.426,95%CI:1.053~1.932)为急诊PCI术后CI-AKI的危险因素(P<0.05)。本研究对各因素乘积进行分析显示各因素间无交互作用(P>0.05)。结论:急诊PCI术后CI-AKI的发生率较高,其主要受患者糖尿病史、低密度脂蛋白胆固醇、基线eGFR、左心室射血分数、造影剂接触时间的影响,临床上可通过加强对上述指标的监测以早期筛查出高危患者。
  • 加载中
  • [1]

    赵甜甜,何壹娜.急性下壁心肌梗死患者行急诊PCI术中发生室性心动过速和心室纤颤的预测因素分析[J].临床急诊杂志,2020,21(5):28-33.

    [2]

    Almendarez M,Gurm HS,Mariani Jr J,et al.Procedural strategies to reduce the incidence of contrast-induced acute kidney injury during percutaneous coronary intervention[J].JACC-Cardiovasc Inte,2019,12(19):1877-1888.

    [3]

    王淑霞,韩洁.对比剂相关急性肾损伤早期诊断生物标志物的研究进展[J].中华老年多器官疾病杂志,2017,16(7):557-560.

    [4]

    Silvain J,Nguyen LS,Spagnoli V,et al.Contrast-induced acute kidney injury and mortality in ST elevation myocardial infarction treated with primary percutaneous coronary intervention[J].Heart,2018,104(9):767-772.

    [5]

    朱俊,杜倩.碘对比剂引起急性肾损伤的相关危险因素分析[J].药物评价研究,2020,43(4):760-764.

    [6]

    Azzalini L,Laricchia A,Regazzoli D,et al.Ultra-low contrast percutaneous coronary intervention to minimize the risk for contrast-induced acute kidney injury in patients with severe chronic kidney disease[J].J Invasive Cardiol,2019,31(6):176-182.

    [7]

    中国医师协会急诊医师分会,中华医学会心血管病学分会,中华医学会检验医学分会.急性冠脉综合征急诊快速诊疗指南[J].中华危重症医学杂志(电子版),2016,9(2):73-80.

    [8]

    Yang Y,George KC,Luo R,et al.Contrast-induced acute kidney injury and adverse clinical outcomes risk in acute coronary syndrome patients undergoing percutaneous coronary intervention:a meta-analysis[J].BMC Nephrol,2018,19(1):374.

    [9]

    Velibey Y,Oz A,Tanik O,et al.Platelet-to-Lymphocyte Ratio Predicts Contrast-Induced Acute Kidney Injury in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention[J].Angiology,2017,68(5):419-427.

    [10]

    Lin KY,Shang XL,Guo YS,et al.Association of preprocedural hyperglycemia with contrast-induced acute kidney injury and poor outcomes after emergency percutaneous coronary intervention[J].Angiology,2018,69(9):770-778.

    [11]

    Lin KY,Wang SY,Jiang H,et al.Negative association between free triiodothyronine level and contrast-induced acute kidney injury in patients undergoing primary percutaneous coronary intervention[J].BMC Nephrology,2019,20(1):201-208.

    [12]

    Lima FV,Singh S,Parikh PB,et al.Left ventricular end diastolic pressure and contrast-induced acute kidney injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention[J].Cardiovasc Revasc Med,2018,19(6S):16-20.

    [13]

    Kuno T,Numasawa Y,Sawano M,et al.Effects of body habitus on contrast-induced acute kidney injury after percutaneous coronary intervention[J].PLoS One,2018,13(9):e0203352.

    [14]

    Lin KY,Chen HC,Jiang H,et al.Predictive value of admission D-dimer for contrast-induced acute kidney injury and poor outcomes after primary percutaneous coronary intervention[J].BMC Nephrol,2020,21(1):90.

    [15]

    Tanik VO,Cinar T,Velibey Y,et al.Neutrophil-to-Lymphocyte Ratio Predicts Contrast-Induced Acute Kidney Injury in Patients with ST-Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention[J].J Tehran Heart Cent,2019,14(2):59-66.

    [16]

    杨倩,朱长清,叶晨安.横纹肌溶解症致急性肾损伤危险因素的Logistic回归分析[J].临床急诊杂志,2020,165(3):61-64,68.

    [17]

    郝岩,潘洋,高洪瑞,等.术前血清脂蛋白a和低密度脂蛋白胆固醇预测急性冠状动脉综合征患者PCI术后短期不良预后价值的比较[J].临床心血管病杂志,2020,36(12):50-54.

    [18]

    Wang Y,Sun WJ,Ji ZS,et al.Serum albumin and the risk of contrast-induced acute kidney injury after percutaneous coronary intervention[J].Rev Cardiovasc Med,2020,21(1):139-145.

    [19]

    Uzunhasan I,Yildiz A,Arslan S,et al.Contrast-induced acute kidney injury is associated with long-term adverse events in patients with acute coronary syndrome[J].Angiology,2017,68(7):621-626.

    [20]

    Zhen G,Dandan N,Yaren Y,et al.Effects of hydration combined with Shenfu injection on contrast-induced acute kidney injury in acute coronary syndrome patients undergoing percutaneous coronary intervention[J].Biomed Rep,2017,7(5):477-481.

  • 加载中
计量
  • 文章访问数:  384
  • PDF下载数:  896
  • 施引文献:  0
出版历程
收稿日期:  2021-03-20

目录